{"resourceType":"MedicationAdministration","id":"MedicationAdministration-Example2","meta":{"profile":["http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-medication-administration"],"security":[{"system":"http://terminology.cibmtr.org/codesystem/transplant-center","code":"rc_99999","display":"99999 My Transplant Center"}]},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicationAdministration MedicationAdministration-Example2</b></p><a name=\"MedicationAdministration-Example2\"> </a><a name=\"hcMedicationAdministration-Example2\"> </a><a name=\"MedicationAdministration-Example2-en-US\"> </a><p><b>status</b>: Completed</p><p><b>medication</b>: <span title=\"Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 4179}, {http://www.nlm.nih.gov/research/umls/rxnorm 310248}, {http://www.nlm.nih.gov/research/umls/rxnorm 362972}, {http://www.nlm.nih.gov/research/umls/rxnorm 206832}\">ETOPOSIDE 20 MG/ML IV SOLN</span></p><p><b>subject</b>: <a href=\"Patient-PatientExample6.html\"> Female, DoB Unknown ( http://terminology.cibmtr.org/identifier/CRID#123456)</a></p><p><b>effective</b>: 2020-07-22 16:58:05+0000</p><p><b>reasonCode</b>: <span title=\"Codes:{http://snomed.info/sct 363346000}, {http://hl7.org/fhir/sid/icd-10-cm C80.1}\">Cancer (CMS/HCC)</span></p><p><b>request</b>: <a href=\"MedicationRequest-MedicationRequest-Etoposide-Example.html\">MedicationRequest: status = active; intent = order; medication[x] = -&gt;etoposide (VEPESID) chemo IVPB; authoredOn = 2020-07-21 14:17:00+0000; reasonCode = Malignant neoplastic disease (disorder)</a></p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td><td><b>Method</b></td><td><b>Dose</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 47625008}\">Intravenous route</span></td><td><span title=\"Codes:{http://snomed.info/sct 422145002}\">Inject - dosing instruction imperative (qualifier value)</span></td><td>73 milligram<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM  codemg = 'mg')</span></td></tr></table></div>"},"status":"completed","medicationCodeableConcept":{"coding":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"4179","display":"etoposide"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"310248","display":"etoposide 20 MG/ML Injectable Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"362972","display":"etoposide Injectable Solution [Vepesid]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","code":"206832","display":"etoposide 20 MG/ML Injectable Solution [Vepesid]"}],"text":"ETOPOSIDE 20 MG/ML IV SOLN"},"subject":{"reference":"Patient/PatientExample6"},"effectiveDateTime":"2020-07-22T16:58:05Z","reasonCode":[{"coding":[{"system":"http://snomed.info/sct","code":"363346000","display":"Malignant neoplastic disease (disorder)"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","code":"C80.1","display":"Malignant (primary) neoplasm, unspecified"}],"text":"Cancer (CMS/HCC)"}],"request":{"reference":"MedicationRequest/MedicationRequest-Etoposide-Example"},"dosage":{"route":{"coding":[{"system":"http://snomed.info/sct","code":"47625008","display":"Intravenous route"}]},"method":{"coding":[{"system":"http://snomed.info/sct","code":"422145002","display":"Inject - dosing instruction imperative (qualifier value)"}]},"dose":{"value":73,"unit":"milligram","system":"http://unitsofmeasure.org","code":"mg"}}}